Interestingly, approximately 30% of patients exposed to long-term venetoclax harbor BAX mutations in the non-CLL compartment together with classical mutations defining clonal hematopoiesis (CH) [134]. The gene discussed is BAX; the disease is B-cell chronic lymphocytic leukemia.